 |
|
Does the old-fashioned sofosbuvir plus ribavirin treatment in genotype 2 chronic hepatitis C patients still works for Koreans?
Jong Eun Yeon
Clin Mol Hepatol. 2018;24(3):294-296. Published online 2018 Sep 11 DOI: https://doi.org/10.3350/cmh.2018.1009
|
|
Citations to this article as recorded by
 Real-Life Effectiveness and Safety of Glecaprevir/Pibrentasvir for Korean Patients with Chronic Hepatitis C at a Single Institution
Young Joo Park, Hyun Young Woo, Jeong Heo, Sang Gyu Park, Young Mi Hong, Ki Tae Yoon, Dong Uk Kim, Gwang Ha Kim, Hyung Hoi Kim, Geun Am Song, Mong Cho
Gut and Liver.2021; 15(3): 440. CrossRef Critical View on the Usage of Ribavirin in Already Existing Psychostimulant-Use Disorder
Branka Petković, Srđan Kesić, Vesna Pešić
Current Pharmaceutical Design.2020; 26(4): 466. CrossRef
|